2. Share Prices
3. Faron Pharmaceuticals Share Price
4. Faron Pharmaceuticals Share News
5. UK earnings, trading statements calendar - next 7 days

Faron Pharmaceuticals Share News (FARN)

• FARN Share
  Price
• FARN Share
  News0
• FARN Share
  Chat1
• FARN Share
  Trades2
• FARN
  Live RNS0
• FARN Share
  Charts
• FARN Level 2
  Console
• FARN Live
  Share Price
• FARN Broker
  Ratings0
• FARN Directors
  Deals0
• FARN Financial
  Diary
• FARN
  Fundamentals
• FARN Short
  Positions0
• FARN
  Media0

• Buy FARN Shares
• Add FARN to Watchlist
• Add FARN to Alert

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 93.00

Bid: 91.00

Ask: 95.00

Change: -1.00 (-1.06%)

Spread: 4.00 (4.396%)

Open: 93.00

High: 94.00

Low: 93.00

Prev. Close: 94.00

Last checked at -

• FARN News
• FARN Professional News

UK earnings, trading statements calendar - next 7 days

Thu, 18th Aug 2022 16:02

Friday 19 August
Apax Global Alpha Ltd	Half Year Results
Kingspan Group PLC	Half Year Results
Newcrest Mining Ltd	Full Year Results
Monday 22 August
Smoove PLC	Full Year Results
Tuesday 23 August
Aferian PLC	Half Year Results
John Wood Group PLC	Half Year Results
Wednesday 24 August
Costain Group PLC	Half Year Results
Lookers PLC	Half Year Results
Standard Chartered PLC	Half Year Results
Thursday 25 August
Amigo Holdings PLC	Q1 Results
Anglo Pacific Group PLC	Half Year Results
Benchmark Holdings PLC	Q3 Results
CRH PLC	Half Year Results
Faron Pharmaceuticals Ltd	Half Year Results
Grafton Group PLC	Half Year Results
Harbour Energy PLC	Half Year Results
Hays PLC	Full Year Results
Hunting PLC	Half Year Results
Macfarlane Group PLC	Half Year Results
Morses Club PLC	Full Year Results
South32 Ltd	Full Year Results
Copyright 2022 Alliance News Limited. All Rights Reserved.

21 Feb 2019 12:17

Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in Faron were up 10% at 64.00 pence on said

Read more

21 Feb 2019 10:09

Faron Pharmaceuticals shares surge on latest Clevegen data

(Sharecast News) - Shares in Faron Pharmaceuticals were surging on Thursday morning, after it announced an update on early observations on immunity and clinical response of MATINS patients after administration of its 'Clevegen' product.

Read more

13 Feb 2019 12:20

Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said new data supports the use of Clever-1 antibodies in re-activating an immune response to tumours.Shares in Faron were up

Read more

19 Dec 2018 11:07

Faron Pharmaceuticals pins some hope to YODA trial

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals issued interim results from its pharmacokinetic/dynamic 'YODA' study on Wednesday, examining various formulations of recombinant human interferon-beta (IFN-beta).

Read more

14 Dec 2018 15:57

Dosing begins in Faron's study of 'Clevegen' drug

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Friday that the first patient has successfully been dosed in the phase I/II MATINS study of Clevegen, its wholly-owned novel precision cancer immunotherapy drug.

Read more

5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more

5 Dec 2018 10:13

Traumakine treatment optimal for particular subgroup, Faron finds

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has identified, by genetic testing, an "optimal subgroup" of acute respiratory distress syndrome (ARDS) patients for Traumakine treatment who showed a substantial reduction in mortality during the INTEREST trial, it announced on Wednesday.

Read more

5 Dec 2018 09:09

Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine

LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, with a certain genetic mutation, to be

Read more

3 Dec 2018 10:50

WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 8.9%, Evraz, up 7.8%, up

Read more

3 Dec 2018 10:09

Faron Pharmaceuticals applies to begin Clevegen clinical trials

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that its clinical trial application to conduct a Phase I/II study with 'Clevegen', its wholly-owned novel precision cancer immunotherapy drug in development for the treatment of selected metastatic or inoperable tumours, has been approved by the Finnish Medicines Agency (FIMEA).

Read more

6 Nov 2018 16:29

DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biopharmaceutical company.In a transaction

Read more

22 Oct 2018 15:32

Faron Reports Corticosteroids Interference In Traumakine Trial

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Monday that it has found evidence suggesting that corticosteroids used in parallel to its Traumakine treatment had a significant effect on a

Read more

17 Sep 2018 10:37

Faron Pharmaceuticals Submits Clinical Trial Application For Clevegen

LONDON (Alliance News) - Faron Pharmaceuticals Oy said Monday it has filed a clinical trial application for its cancer immunotherapy drug Clevegen.Clevegen, an anti-Clever-1 antibody, the a

Read more

13 Sep 2018 10:49

WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Royal Bank a

Read more

13 Sep 2018 10:30

Faron Pharmaceuticals Falls As Interim Loss Widens On Research Costs

LONDON (Alliance News) - Shares in Faron Pharmaceuticals Ltd dropped on Thursday after the company said its loss for the first half of its financial year increased on higher research were trading

Read more